Last update 16 May 2025

OPB-111001

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
OPB 111001
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseMouth and Tooth Diseases+ [3]
Active Indication-
Inactive Indication
Advanced cancerBreast CancerCervical Squamous Cell Carcinoma+ [5]
Originator Organization
Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd.
Active Organization-
Inactive Organization
Otsuka Novel Products GmbHOtsuka Novel Products GmbH
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with OPB-111001
NCT02042885
/ TerminatedPhase 1/2
A Two-part Phase 1/2a, Open-label, Dose Escalation Study to Evaluate the Tolerability and Preliminary Antitumour Activity of OPB-111001 in Patients With Advanced Cancers That Are Poorly Responsive to Standard Anticancer Treatment
100 Clinical Results associated with OPB-111001
Login to view more data
100 Translational Medicine associated with OPB-111001
Login to view more data
100 Patents (Medical) associated with OPB-111001
Login to view more data
100 Deals associated with OPB-111001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 2
United Kingdom
Otsuka Novel Products GmbHOtsuka Novel Products GmbH
01 Jan 2014
Breast CancerPhase 2
United Kingdom
Otsuka Novel Products GmbHOtsuka Novel Products GmbH
01 Jan 2014
Cervical Squamous Cell CarcinomaPhase 2
United Kingdom
Otsuka Novel Products GmbHOtsuka Novel Products GmbH
01 Jan 2014
Endometrial CarcinomaPhase 2
United Kingdom
Otsuka Novel Products GmbHOtsuka Novel Products GmbH
01 Jan 2014
Ovarian CancerPhase 2
United Kingdom
Otsuka Novel Products GmbHOtsuka Novel Products GmbH
01 Jan 2014
Prostatic CancerPhase 2
United Kingdom
Otsuka Novel Products GmbHOtsuka Novel Products GmbH
01 Jan 2014
Salivary Gland NeoplasmsPhase 2
United Kingdom
Otsuka Novel Products GmbHOtsuka Novel Products GmbH
01 Jan 2014
Squamous Cell CarcinomaPhase 2
United Kingdom
Otsuka Novel Products GmbHOtsuka Novel Products GmbH
01 Jan 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free